Skip to main content

Working from home means softer toilet paper—and a significant toll on the environment

With Americans spending a lot of time at home these days, more money is being spent on soft toilet paper. That may be bad news for the environment.

The kind of cushy tissue that was sold out earlier in the pandemic uses material that comes primarily from clear-cutting forests, according to the Natural Resources Defense Council. Office buildings, on the other hand, tend to use recycled fibers in their toilet paper, the group said.

“The side-effect of one crisis shouldn’t exacerbate another,” said Shelley Vinyard, an environment expert with the NRDC, which released a report Wednesday on the climate impact of toilet paper. “There’s no real reason why office tissue has to be made with recycled and the consumer tissue has to be made with virgin fiber.”

Nearly 60% of at-home toilet paper in the U.S. comes from so-called virgin material, which is sourced from Canada’s northern forests. The NRDC for years has highlighted the impact of tissue that uses non-recycled content.

In the latest study, the group handed out F grades to brands from Procter & Gamble Co., Georgia-Pacific, and Kimberly-Clark Corp.—the three largest U.S. manufacturers of toilet paper—for the environmental impact of their products.

P&G said via email that its popular Charmin brand is “sourced from responsibly-managed forests,” and that at least one tree is regrown for every one the company uses. A Georgia-Pacific representative referred to an earlier statement that said the company is committed to sustainability and that Canada in particular has regulations in place to help minimize the risk of deforestation.

‘Complex challenges’

Kimberly-Clark has committed to reducing the use of virgin wood fiber from natural forests in its tissue products by 50% by 2025, said Terry Balluck, a company spokesperson. “We understand the point of view of the NRDC, and we remain committed to the ongoing dialogue with them on the complex challenges presented in their report.“

The heavy reliance on virgin fibers is releasing an “enormous pandora’s box” of carbon emissions, said Jennifer Skene, a co-author of the NRDC report along with Vinyard. Logging in the Canadian boreal forests region, which stretches from the Yukon to Newfoundland, emits 26 million metric tons every year, the report estimates, an amount which is equivalent to the emissions produced by 5.5 million passenger vehicles.

As tissue remains one of the fastest-growing sectors in the paper industry, investments in virgin fibers will likely continue in years to come, according to the NRDC, which is headquartered in New York.

More must-read stories from Fortune:



from Fortune https://ift.tt/2Nr1NgT

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be